ALDH1A3 and cancer: To assess the selectivity of the identified ALDH1A3 inhibitor, VS1 was docked into the binding sites of other homologous ALDH isoforms 1A1, 1A2, 3A1, and 7A1, which are overexpressed in various cancer types as well as in normal human tissues.